| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2849273 | American Heart Journal | 2006 | 7 Pages |
Abstract
Greater STâ is associated with other adverse prognosticators across the broad spectrum of non-ST-elevation ACS. Although the presence of any STâ is an independent predictor of 1-year mortality, its quantitative assessment is not as important as its mere presence when studied on the background of comprehensive clinical and biomarker evaluation in a nonclinical trial-based ACS population.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Andrew T. MD, Raymond T. MD, Mary BSc, Chi-Ming MDCM, MSc, David H. MD, Alina A. MD, Quamrul MD, Janna MD, Anatoly MD, MSc, Shaun G. MD, MSc, for the Canadian ACS Registry Investigators for the Canadian ACS Registry Investigators,